TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
15 avr. 2024 09h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
28 mars 2024 08h30 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
$75+ Billion In Vitro Diagnostic (IVD) Reagents Markets: Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes - Global Forecast to 2030
01 mars 2024 03h46 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry,...
Oligonucleotide Synthesis Market Poised for Exponential Growth in Healthcare and High-Tech Applications - New Research Report Forecasts 2023-2027 Trends and Insights
26 févr. 2024 03h19 HE
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
RNA Therapeutics Market Research Report 2023: Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Global Forecast to 2028
31 janv. 2024 05h59 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious...
Transfection Reagents and Equipment Global Market Report 2024: Market Set to Soar with Emerging Trends and Growing Healthcare Expenditures - Long-term Forecasts to 2028 and 2033
25 janv. 2024 09h32 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for...
Global Oligonucleotide Synthesis Market Analysis and Opportunity Forecast 2023-2028 - RNA-based Therapeutics Show Promise, Boosting Demand for Tailored Oligonucleotides
10 janv. 2024 11h23 HE
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Oligonucleotide Synthesis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
06 déc. 2023 07h00 HE
|
Ractigen Therapeutics
This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
Global Gene Therapy Research Report 2023-2028: Increasing Regulatory Approvals, Growing Investments, Rising Demand for Cell & Gene Therapies
17 nov. 2023 09h13 HE
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area...
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
02 nov. 2023 08h00 HE
|
Ractigen Therapeutics
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting